Shares of Osiris Therapeutics Inc. fell Monday after the company said it is still negotiating with French drugmaker Sanofi about the rights to its stem cell therapy Prochymal. Continue reading
Tag Archives: sanofi
Another Nod for Osiris' Prochymal
Just a few weeks after gaining approval in Canada, Osiris Therapeutics, Inc.s (OSIR) stem cell therapy, Prochymal, gained approval in New Zealand. Prochymal gained approval for the treatment of acute graft-vs-host disease (GvHD) in children Continue reading